BACKGROUND AND PURPOSE: Conventional imaging of ex-vivo brain at 1.5T in multiple sclerosis (MS) detects only a small fraction of the gray matter cerebral cortical lesions that can be detected by pathology. Our purpose was to examine if imaging at 8T can detect plaques in cortical gray matter (CGM) not evident at 1.5T. METHODS: An ex-vivo brain obtained at autopsy from a patient with MS was formalin fixed and 1 cm coronal slices were examined using MR imaging at 8T. RESULTS: Numerous cerebral cortical lesions not evident at 1.5T were seen at 8T. Lesions were easily identified using gradient-echo and spin-echo (SE) as well as diffusion images. MR imaging at 8T identified many of the types of plaques previously evident only by pathology. The magnitude of the cortical involvement in this 1 patient was severe. Lesions in the gray matter readily visible by high-field MR imaging were sometimes barely visible by pathology. MR imaging at 8T often facilitated the detection of such plaques by pathology. CONCLUSION: This study establishes the utility of high-field imaging at 8T in the delineation of plaques in the cerebral CGM in MS.
BACKGROUND AND PURPOSE: Conventional imaging of ex-vivo brain at 1.5T in multiple sclerosis (MS) detects only a small fraction of the gray matter cerebral cortical lesions that can be detected by pathology. Our purpose was to examine if imaging at 8T can detect plaques in cortical gray matter (CGM) not evident at 1.5T. METHODS: An ex-vivo brain obtained at autopsy from a patient with MS was formalin fixed and 1 cm coronal slices were examined using MR imaging at 8T. RESULTS:Numerous cerebral cortical lesions not evident at 1.5T were seen at 8T. Lesions were easily identified using gradient-echo and spin-echo (SE) as well as diffusion images. MR imaging at 8T identified many of the types of plaques previously evident only by pathology. The magnitude of the cortical involvement in this 1 patient was severe. Lesions in the gray matter readily visible by high-field MR imaging were sometimes barely visible by pathology. MR imaging at 8T often facilitated the detection of such plaques by pathology. CONCLUSION: This study establishes the utility of high-field imaging at 8T in the delineation of plaques in the cerebral CGM in MS.
Authors: P M Robitaille; R Warner; J Jagadeesh; A M Abduljalil; A Kangarlu; R E Burgess; Y Yu; L Yang; H Zhu; Z Jiang; R E Bailey; W Chung; Y Somawiharja; P Feynan; D L Rayner Journal: J Comput Assist Tomogr Date: 1999 Nov-Dec Impact factor: 1.826
Authors: A Kangarlu; R E Burgess; H Zhu; T Nakayama; R L Hamlin; A M Abduljalil; P M Robitaille Journal: Magn Reson Imaging Date: 1999-12 Impact factor: 2.546
Authors: Jeroen J G Geurts; Lars Bö; Petra J W Pouwels; Jonas A Castelijns; Chris H Polman; Frederik Barkhof Journal: AJNR Am J Neuroradiol Date: 2005-03 Impact factor: 3.825
Authors: I Catalaa; J C Fulton; X Zhang; J K Udupa; D Kolson; M Grossman; L Wei; J C McGowan; M Polansky; R I Grossman Journal: AJNR Am J Neuroradiol Date: 1999-10 Impact factor: 3.825
Authors: M P Amato; M L Bartolozzi; V Zipoli; E Portaccio; M Mortilla; L Guidi; G Siracusa; S Sorbi; A Federico; N De Stefano Journal: Neurology Date: 2004-07-13 Impact factor: 9.910
Authors: Essa Yacoub; Timothy Q Duong; Pierre-Francois Van De Moortele; Martin Lindquist; Gregor Adriany; Seong-Gi Kim; Kâmil Uğurbil; Xiaoping Hu Journal: Magn Reson Med Date: 2003-04 Impact factor: 4.668
Authors: J Cohen-Adad; T Benner; D Greve; R P Kinkel; A Radding; B Fischl; B R Rosen; C Mainero Journal: Neuroimage Date: 2011-04-13 Impact factor: 6.556
Authors: M Filippi; M A Rocca; F Barkhof; R Bakshi; F Fazekas; O Khan; D Pelletier; A Rovira; J Simon Journal: AJNR Am J Neuroradiol Date: 2011-02-03 Impact factor: 3.825
Authors: J M Stankiewicz; M Neema; D C Alsop; B C Healy; A Arora; G J Buckle; T Chitnis; C R G Guttmann; D Hackney; R Bakshi Journal: J Neurol Sci Date: 2009-04-15 Impact factor: 3.181
Authors: Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi Journal: Lancet Neurol Date: 2008-07 Impact factor: 44.182
Authors: D H Miller; B G Weinshenker; M Filippi; B L Banwell; J A Cohen; M S Freedman; S L Galetta; M Hutchinson; R T Johnson; L Kappos; J Kira; F D Lublin; H F McFarland; X Montalban; H Panitch; J R Richert; S C Reingold; C H Polman Journal: Mult Scler Date: 2008-09-19 Impact factor: 6.312